Researchers at the COVID-19 Prevention Network — headquartered at the Fred Hutchinson Cancer Research Center in Seattle — are conducting the “Prevent COVID U” study, which launched March 25 at 21 college campuses.
Researchers aim to enroll 12,000 students nationwide who will perform daily nose swabs for four months. Half will receive Moderna’s vaccine the day they enroll, and the other half will get vaccinated after the four-month period. Researchers will also identify 25,000 close contacts of study participants to assess the degree of transmission from vaccinated students.
“We hope that within the next five or so months, we’ll be able answer the very important question about whether vaccinated people get infected asymptomatically, and if they do, do they transmit the infection to others,” Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, said of the trial during a March 26 White House briefing.
The institute is funding the study.
To learn more, click here.
More articles on public health:
Epidemiologist Dr. Michael Osterholm on what the UK variant means for the pandemic’s 3rd act
Physician viewpoint: Herd immunity may be closer than you think
|US sees 8 weeks of minimal flu activity — 5 CDC FluView takeaways
